PARIS--(MARKET WIRE)--May 20, 2008 -- BioAlliance acquired European rights for Ondansetron oral spray to complement its franchise in cancer supportive care from NovaDel Pharma Inc. Paris, May 20, 2008 - BIO) a specialty pharmaceutical company focused on the treatment of opportunistic infections...
[read full story]